Navigation Links
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Date:8/19/2007

atment of metastatic colorectal cancer across the U.S. and in Europe. Patients are randomized to two arms containing either CoFactor or leucovorin, each in combination with the widely used cancer chemotherapy regimen of 5-FU and bevacizumab (Avastin(R)). The primary endpoint for the study is progression-free survival. Secondary endpoints include response rate, overall survival and incidence and severity of adverse events. The protocol and planned analysis were developed with and accepted by the FDA under a Special Protocol Assessment.

About ANX-510, or CoFactor

CoFactor is a folate-based biomodulator drug designed to replace leucovorin as the preferred method to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-FU. In comparison to leucovorin, CoFactor creates more stable binding of the active form of 5-FU to the target enzyme, thymidylate synthase (TS). CoFactor bypasses the metabolic pathway required by leucovorin to deliver the active form of folate, allowing 5-FU to work more effectively. CoFactor is in Phase 3 and Phase 2b clinical trials for the treatment of metastatic colorectal cancer, as well as in a Phase 2 clinical trial for the treatment of advanced breast cancer.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. The Company seeks to improve the performance and safety of existing treatments by addressing significant problems, such as drug metabolism and bioavailability, excessive toxicity and treatment resistance. More information can be found on ADVENTRX's web site at http://www.adventrx.com.

Forward-Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
2. Adventrx Announces Positive Data From Multidrug Therapy With CoFactor
3. ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... /PRNewswire/ – Small Cap IR issues report. Recently, Arrayit ... Arrayit blood card technology to Vivos, Global Genome Vault, ... offers an impervious, impenetrable and permanent DNA storage vault, ... on Earth, a safe and secure nuclear blast-proof, underground ... the rapid collection, separation, drying and storage of human ...
(Date:6/30/2015)... , June 30, 2015  Egalet Corporation ... integrated specialty pharmaceutical company focused on developing, ... announced top-line results from a Category 3 ... an abuse-deterrent, extended-release, oral oxycodone product candidate ... of pain severe enough to require daily, ...
(Date:6/30/2015)... 2015 PharmaVentures is pleased to ... Technologies Oy (CMT) on its divestment of certain assets ... CMTs world leading capabilities in cellular imaging and analysis. ... series of successful global deals in the life science ... Fintan Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted ...
Breaking Medicine Technology:Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
(Date:6/30/2015)... ... June 30, 2015 , ... In the Spring of 2015, ... in the Sierra Nevada mountains measured zero for the first time since records have ... of one of its most sustained periods of increasing drought.” , In ...
(Date:6/30/2015)... , ... June 30, 2015 , ... America is in ... disease, cancer, autism, dementia, auto-immune deficiencies, or obesity. Why? , The answer is simple ... Pete Sulack, America’s Leading Stress Expert, has successfully treated over one million patients and, ...
(Date:6/30/2015)... ... ... a reliable source for cheap tickets for Journey at the Stadium of Fire ... venues for years and they are one of the most beloved musical acts in the ... While Journey is known for their all-around great sound, fans of the group will undoubtedly ...
(Date:6/30/2015)... Los Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... 18th Newswise article, early humans who lived three to four hundred thousand ... important to overall health. By examining the chemical compounds in fossilized, ancient dental plaque, ...
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, ... announce it’s own Debby Mann, CPC, RCC, ROCC, Coding Documentation and Education Manager, ... the Special Recognition Award for her contribution to the RBMA Coding Subcommittee. ...
Breaking Medicine News(10 mins):Health News:RainSoil launches water-retention product as drought spreads. 2Health News:RainSoil launches water-retention product as drought spreads. 3Health News:12 Easy-To-Follow Steps to Transform Body, Mind and Spirit 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2
... interest for most women , WEDNESDAY, March 17 (HealthDay ... pregnancy progresses, they don,t enjoy the experience any less, ... health for many years, and we have not studied ... past, and there,s a gender information gap," said Dr. ...
... , WASHINGTON , March 17 The ... closure is Montgomery Cancer Center in Selma, Alabama . ... clinic closures over the past several months --with the majority ... severe cuts in Medicare reimbursement for cancer care. Yet the ...
... RACINE, Wis. , March 17 SC Johnson, A Family ... (BMGF) on global efforts to combat malaria. The organizations will jointly support ... Enterprise and a consortium of Indonesian research institutions to advance the development ... the disease. , ...
... Digital Director , ... , , ... ... WASHINGTON , March 17 The Health IT Now! Coalition hosted ...
... , March 17 A person with fibromyalgia experiences daily pain all over their body. Even ... with Pfizer Inc., has developed a video on the "Science of Fibromyalgia" as a resource to help people ... ... , ...
... Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel ... to be hospitalized for upper digestive tract bleeding than those who used clopidogrel ... and Quality and the National Heart, Lung, and Blood Institute at the National ... ...
Cached Medicine News:Health News:Sexual Desire, Satisfaction Don't Diminish During Pregnancy 2Health News:Sexual Desire, Satisfaction Don't Diminish During Pregnancy 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 2Health News:Latest Cancer Clinic Closure in Selma, Alabama 3Health News:Latest Cancer Clinic Closure in Selma, Alabama 4Health News:SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria 2Health News:SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria 3Health News:SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria 4Health News:Panel: FCC's Broadband Plan Will Boost Efforts to Expand Health IT 2Health News:Panel: FCC's Broadband Plan Will Boost Efforts to Expand Health IT 3Health News:Panel: FCC's Broadband Plan Will Boost Efforts to Expand Health IT 4Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 2Health News:VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia 3Health News:Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers 2Health News:Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers 3
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Cobb Spinal Curettes, tip size 13.00 mm, length 11" (279 mm)....
Karlin XL Magnum Ring Curettes, extra long (XL) curettes, black handles, lightweight. Length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
Medicine Products: